Zscaler (ZS) shares dropped 9% despite crushing Q2 earnings estimates and raising full-year guidance. Learn why investors sold off the stock. The post Zscaler StockZscaler (ZS) shares dropped 9% despite crushing Q2 earnings estimates and raising full-year guidance. Learn why investors sold off the stock. The post Zscaler Stock

Zscaler Stock Plunges 9% After Strong Q2 Results and Raised Outlook

2026/02/27 18:45
3 min read

TLDR

  • Zscaler delivered Q2 FY2026 adjusted EPS of $1.01 on $816M revenue, surpassing Wall Street projections
  • Shares plummeted 9% in Friday’s pre-market session following the earnings announcement
  • Raised full-year EPS forecast to $3.99–$4.02, exceeding the $3.92 analyst consensus
  • YTD performance shows a 26% decline, mirroring broader software sector valuation concerns
  • Company operates at a “Rule-of-62” efficiency metric, significantly surpassing the Rule-of-40 industry standard

Zscaler $ZS delivered impressive fiscal Q2 results, yet investors responded by sending shares lower. This reaction encapsulates the current state of software sector trading.

The cloud security provider reported adjusted earnings of $1.01 per share, beating analyst expectations of $0.89 by a significant $0.12 margin. The company generated $815.8 million in revenue, representing 26% annual growth and exceeding consensus projections of $798 million.

Yet these strong results weren’t enough to lift the stock, which declined approximately 9% during Friday’s pre-market session.


ZS Stock Card
Zscaler, Inc., ZS

The week proved volatile for ZS shareholders. Monday saw a 10% plunge amid AI-driven market turbulence. The following three trading days brought a 17% recovery before Thursday’s earnings release triggered another downturn.

Looking ahead to Q3 FY2026, Zscaler projects adjusted EPS between $1.00 and $1.01, comfortably above the $0.95 Wall Street consensus. The company anticipates revenue in the $834 million to $836 million range, modestly exceeding analyst estimates of $831.9 million.

Management elevated full-year FY2026 guidance, now targeting adjusted EPS of $3.99–$4.02 versus the previous $3.82 consensus. Annual revenue expectations were set at $3.309 billion to $3.322 billion, slightly above the $3.3 billion estimate.

CEO Jay Chaudhry emphasized the company’s strategic positioning around artificial intelligence, noting that enterprises accelerating AI deployment are leveraging Zscaler’s infrastructure to protect AI-powered and agentic systems.

Rule-of-62

CFO Kevin Rubin highlighted an impressive operational efficiency metric. Zscaler is currently operating at a “Rule-of-62” on a fiscal year-to-date basis.

This metric blends revenue growth rate with profit margins. While the Rule-of-40 represents the baseline for healthy software businesses, Zscaler’s performance substantially exceeds this threshold.

A Rough Year for ZS

Prior to the earnings release, ZS had already fallen 26% in 2026. The post-earnings selloff compounds the challenges facing a stock that has struggled to gain traction throughout the year.

This week’s price action illustrates the current mindset among software investors. A 10% decline, followed by a 17% recovery, then another sharp drop despite strong results—the market remains indecisive about proper valuations for these companies.

The Q3 forecast calling for $834–$836 million in revenue and EPS of $1.00–$1.01 continues to exceed analyst projections.

The post Zscaler Stock Plunges 9% After Strong Q2 Results and Raised Outlook appeared first on Blockonomi.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.